Shanghai Pharma: Cilnidipine Emulsion Injection Approved for Production

36Kr reports that Shanghai Pharma announced its subsidiary, Shanghai Yuhua First Biochemical Pharmaceutical Co., Ltd., received the "Drug Registration Certificate" for cilnidipine emulsion injection from the National Medical Products Administration. The drug has been approved for production and is primarily used to treat hypertension in patients who are unsuitable for oral medication or for whom oral therapy is ineffective.